🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

HHS HHS

Company Profile ↓
$2.26
-33.72% 1Y
Mkt Cap$27.62M
P/E-20.55
P/B1.35
52W High$3.91
52W Low$2.00
Book Value$1.68
EPS (TTM)$-0.11

Company Overview

HHS (HHS) is a publicly traded company listed on with a market capitalization of $27.62M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Recent Developments

  • Dec 2025 Revenue of $159.57M (-13.9% YoY); net profit $-811.00K.
  • Trailing 12 Months Year-on-year growth — revenue -13.9%.
  • 5-Year Trend Long-term compounding — revenue CAGR -10.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-9.99%
1 Year:-13.86%

Stock Price Performance

1 Year:-33.72%
6 Months:-26.38%
3 Months:-18.41%
1 Month:-2.16%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 14% of range
$2.00 $3.91
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)47.49 · Neutral
Price Performance
1M-2.16%
3M-18.41%
6M-26.38%
1Y-33.72%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Revenue declined at -10.0% CAGR over 5 years.
  • Trading 42.2% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-20.55
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$1.68
Price to Book
1.35
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-9.99%
Profit 5Y
-
Revenue (YoY)
-13.86%
Earnings (YoY)
-

Profitability & Returns

ROCE
0.63%
ROE
-3.95%
ROA
-0.88%
Profit Margin
-0.51%
Op Margin
0.24%
Gross Margin
-
EPS (Latest Qtr)
$-0.08
EPS (TTM)
$-0.11

Balance Sheet & Liquidity

Debt/Equity
1.09
Quick Ratio
-
Current Ratio
1.54
Debt
$22.40M
Total Assets
$90.41M
Current Assets
$46.32M
Working Capital
$16.15M

Ownership

Promoter Holding
47.31%
Chg in Prom Hold
-
FII / Inst Holding
31.72%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$159.57M
EBITDA
-
Free Cash Flow
$-4.49M
Operating Cash Flow
$-1.74M
Shares Outstanding
12.22M
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2014Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ----------94.89M94.72M94.42M99.87M81.20M69.63M63.59M70.21M59.15M54.69M51.41M40.52M41.60M47.70M43.75M49.26M49.60M49.06M48.55M53.89M47.12M47.76M47.12M45.45M45.03M47.63M41.56M38.63M39.52M37.26M
Operating Income 10.54M14.66M-258.00K3.04M-209.64M3.59M-8.55M-6.69M-4.09M-34.51M-6.34M-1.79M950.00K-33.68M-5.04M-6.31M-10.35M-4.34M-10.94M-6.61M-4.47M-5.11M-5.88M785.00K-884.00K1.44M4.23M3.89M4.01M3.77M1.05M1.67M2.91M375.00K1.37M1.90M-40.00K34.00K509.00K-768.00K
Net Income -----------7.39M-2.65M-2.48M-29.34M32.63M-6.73M-9.98M1.64M-13.53M-3.80M-5.99M5.12M-6.24M-1.62M-1.76M10.57M4.40M3.35M4.46M7.17M-791.00K580.00K618.00K-171.00K-27.83M142.00K-392.00K-335.00K-2.29M-628.00K
Diluted EPS 0.100.160.03-0.07-2.770.04-0.09-0.07-0.05--1.20-0.43-0.40-4.734.67-1.10-1.620.21-2.18-0.63-0.970.67-0.99-0.27-0.281.270.520.390.520.83-0.110.080.08-0.02-3.840.02-0.05-0.05-0.31-0.08

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 860.14M820.72M614.27M581.09M559.61M499.44M444.17M404.41M383.91M284.63M217.58M176.90M194.60M206.28M191.49M185.24M159.57M
Operating Income 82.43M93.25M72.26M62.67M42.66M25.29M-197.95M-53.84M-40.87M-26.03M-21.61M-10.58M7.64M15.11M3.36M2.09M386.00K
Net Income 47.72M53.60M44.20M-83.35M13.37M23.99M-170.93M-130.94M-41.86M17.55M-26.26M-1.69M14.97M36.78M-1.57M-30.30M-811.00K
Diluted EPS 0.750.840.70-1.320.210.38-27.73-21.29-6.762.38-4.26-0.341.764.75-0.21-4.15-0.11

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --926.88M932.51M706.21M685.54M644.18M414.41M213.44M130.81M125.17M110.20M119.50M-119.98M122.76M101.78M91.83M
Current Assets --------------66.31M65.21M53.61M46.32M
Cash & Equivalents 30.16M86.60M84.89M85.93M49.38M84.93M53.33M16.56M46.01M8.40M20.88M28.10M29.41M-10.36M18.36M9.93M5.59M
Inventory ------------------
Receivables --------------39.70M34.31M31.65M27.84M
Total Liabilities --489.06M486.16M378.05M336.48M317.50M274.10M210.78M165.45M134.64M150.16M162.90M-101.18M102.90M80.09M71.30M
Current Liabilities --280.96M203.65M129.91M140.84M124.27M98.13M104.67M67.25M54.16M45.53M47.19M-43.57M48.11M35.14M30.16M
Long Term Debt --60.00M110.25M98.00M82.69M64.31M74.11M0014.20M18.70M22.17M5.00M----
Total Debt --------------22.32M28.51M24.60M22.40M
Total Equity 356.37M401.64M437.82M446.36M328.16M349.05M326.68M140.32M2.66M-34.63M-19.18M-49.68M-53.12M-18.81M19.86M21.69M20.53M
Shares Outstanding --------------12.22M12.22M12.22M12.22M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 114.02M95.87M61.91M76.38M59.57M26.02M33.29M14.59M-30.80M-9.18M12.10M-7.84M-1.76M28.79M10.48M-2.99M-1.74M
Investing Cash Flow -8.87M-30.15M-18.85M-13.32M10.35M-11.16M-36.14M99.70M-5.67M-52.00K-2.60M-775.00K-2.90M-11.49M-2.31M-3.74M-2.76M
Financing Cash Flow -49.48M-66.25M-42.18M-99.83M-30.02M-44.63M-31.94M-85.30M-1.46M22.73M3.09M7.31M-13.41M-15.82M-3.22M-419.00K514.00K
Capital Expenditure -9.01M-17.20M-22.34M-13.46M-15.87M-9.12M-7.91M-6.69M-5.68M-4.21M-2.90M-2.70M-3.05M-5.80M-2.81M-3.75M-2.76M
Free Cash Flow 105.01M78.67M39.57M62.92M43.70M16.90M25.38M7.90M-36.48M-13.39M9.20M-10.54M-4.81M22.99M7.67M-6.73M-4.49M
Share Buybacks 008.36M4.40M1.76M7.35M4.62M00----02.37M0-
Dividends Paid 19.12M19.14M20.37M26.96M16.12M21.48M21.24M5.29M0--------

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -----------------
Operating Margin % 9.6%11.4%11.8%10.8%7.6%5.1%-44.6%-13.3%-10.6%-9.1%-9.9%-6.0%3.9%7.3%1.8%1.1%0.2%
Net Margin % 5.5%6.5%7.2%-14.3%2.4%4.8%-38.5%-32.4%-10.9%6.2%-12.1%-1.0%7.7%17.8%-0.8%-16.4%-0.5%
ROE % 11.9%12.2%9.9%-25.4%3.8%7.3%-121.8%-4,929.9%120.9%-91.5%52.9%3.2%-195.5%-7.9%-139.7%-4.0%
ROCE % -14.4%9.9%10.9%7.8%4.9%-62.6%-49.5%-64.3%-36.7%-33.4%-14.6%-19.8%4.5%3.1%0.6%

Shareholding Pattern

Insiders
47.31%
Institutions
31.72%
Public Float
60.21%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for HHS

Google News Sat, 01 Aug 2026

Enterprise value to EBITDA forward of Harte Hanks, Inc. – NASDAQ:HHS - TradingView

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOSlh2VjJhNk1XTF9XYXR5Q0FCRVVtUkVBSmRPb1B5cGxhVk1idWt2Szk3NWhpbUxvWU12al9Meno0NUt6eF9Ib0p2UzVYbENNRXlTb1JtR0tfa2dwcWJ4N3JUMmdFWmFmSjhZODVibFpleGpKVDh3d3l6ZHJrUFJ4bXB5eHB3YWhYNWxza2…

Google News hu, 28 May 2026

An HHS Official’s Stock Trading Is Raising Flags - News of the United States - NOTUS

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE1QbGRLLWhHNWtKejNZcGpBeGdCb3NMV2Q0N3Q3YkZPMkpuOEFWeXJEV2p1ZkRTRVV3RlVZQTBRNjVZMFBVQXNBRDlMZlVqTE9SbjdlUktvanktRDl2OGJFR083ZWtpZld2Mnc?oc=5" target="_blank">An HHS Official’s Stock …

Google News Mon, 20 Jul 2026

NeoGenomics Had Accrued an $11.2M Reserve for OIG Probe - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNTmRLdWdEY1dXLVI2M1NOcnpDMDVnYjI5V1NlNnZ5TXgtRXRsbmc0bTlfT3RnUWQyMElJMkZ6RmNCV0ZOZEY4QzJYUWNJYjY4RmNSV0FBd0xjNE9ZWFlLUTN6c1duX09wU1dUY1Rhc1AzVU5iWkI4SWIydVl4R05LTFNGRzEyTzRmMEw5NW…

Google News Sat, 01 Aug 2026

HHS Q2 2025 Earnings: Net Loss of $0.05 Per Share Accompanied by a 0.68 Decline in Shares - Earnings Call Q&A - dars.gov.et

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxQOHBQUzQtZ0ZNZnJvT3pJR0dGSjdLbldZcXNBaktrOWtQXy1mOGtiUjNheW5ySllCdXA1a25GcjUzLUJHWnJoSVRGalpMTnN5SFlWcDlkclZfM2o1Q2FJanYwQ283Z3U0cUtLbXBIOER3R1l3ZE5GTjMwbXlURHRaWTBjd1UwRDhoczZSdn…

Google News Wed, 03 Jun 2026

Top HHS Lawyer Reassigned After Stock Trading Rebuke - News of the United States - NOTUS

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1UQWt2WEdubnRmN05FT0tFTlJwU3VSal8xSERXbE5RdEVSR2Q5U0ZVOEMtNXVmWlIxT29uTnp1dFdKWnNWbGhPa3JJVzhPY1dEd0R3ZXEtTGs0ZXB0dlhwYnpBQnlUX2lGc0sw?oc=5" target="_blank">Top HHS Lawyer Reassign…

Google News Sun, 26 Jul 2026

Harte Hanks, Inc. Revenue Breakdown – NASDAQ:HHS - TradingView

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9xSGlfdGZMendfc1RIalk3X1c3WlpURXB1OGJrdFQzc2Z2WEJuYXBuY3BpQjBJcVVqbFhzTTVWNkdlUGNaM2s2a19Ea3E2WUI1QzJPRjJod1U0aUh2WmJ4XzF6ZGtITGJuMWhQVDc3aHdvQ1pqalE?oc=5" target="_blank">Harte Ha…

HHS — Frequently Asked Questions

What is the current share price of HHS?

As of 2026-08-05 17:25 PDT, HHS trades at $2.26 on NASDAQ/NYSE. Its 52-week range is $2.00 to $3.91.

What is the market capitalisation of HHS?

HHS has a market capitalisation of $27.62M on NASDAQ/NYSE.

What is the P/E ratio of HHS?

HHS trades at a trailing price-to-earnings (P/E) ratio of -20.55. Its price-to-book (P/B) ratio is 1.35.

What is the return on equity (ROE) of HHS?

HHS has a return on equity (ROE) of -3.95%. Its return on capital employed (ROCE) is 0.63%.

Is HHS a good stock to buy?

This page provides a data-driven analysis of HHS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space